Correction: Multilocus Sequence Typing as a Replacement for Serotyping in Salmonella enterica.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

1. [Clinical and drug sensitivity characteristics of invasive non-typhoidalZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
   Article
2. Population structure analysis ofFrontiers in microbiology · 2025
   Article
3. Salmonella infections in Denmark from 2013-2022 with focus on serotype distribution, invasiveness, age, sex, and travel exposition.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
   Article
4. Hunted Wild Boars in Sardinia: Prevalence, Antimicrobial Resistance and Genomic Analysis ofFoods (Basel, Switzerland) · 2023
   Article

Corrections and comments

• Erratum for
  Multilocus sequence typing as a replacement for serotyping in Salmonella enterica.2012

Authors and funding

14 authors.

Funding

Abstract